These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12760714)

  • 21. Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin.
    Alavian SM; Tabatabaei SV
    Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):123-4. PubMed ID: 19959942
    [No Abstract]   [Full Text] [Related]  

  • 22. Has genetics eradicated the good old predictors of hepatitis C treatment response?
    Pawlotsky JM
    Clin Res Hepatol Gastroenterol; 2011 Mar; 35(3):157-8. PubMed ID: 21492738
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of chronic hepatitis C in patients not responding to interferon].
    Moreno Monteagudo JA; García Buey L; Moreno Otero R
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():51-6. PubMed ID: 11968345
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of chronic hepatitis C. Combined treatment in naive patients].
    Forns Bernhardt X
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():43-6. PubMed ID: 11968343
    [No Abstract]   [Full Text] [Related]  

  • 25. SEN viruses and treatment response in chronic hepatitis C virus.
    Naoumov NV
    Lancet; 2002 May; 359(9319):1779-80; author reply 1780. PubMed ID: 12049896
    [No Abstract]   [Full Text] [Related]  

  • 26. First-line treatments for hepatitis C.
    Messori A; Del Santo F; Maratea D
    Aliment Pharmacol Ther; 2011 Jun; 33(12):1383-5. PubMed ID: 21569068
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pegylated interferon plus ribavirin combination therapy for chronic hepatitis C].
    Hiramatsu N; Oze T
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():238-42. PubMed ID: 26845937
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of hepatitis C. Paris 27-28 February 2002].
    Ann Med Interne (Paris); 2002 Nov; 153(7):467-77. PubMed ID: 12598833
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of hepatitis C in intravenous drug users].
    Filoche B
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B252-6. PubMed ID: 12180298
    [No Abstract]   [Full Text] [Related]  

  • 30. Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3.
    Tapper EB; Afdhal NH
    J Viral Hepat; 2013 Oct; 20(10):669-77. PubMed ID: 24010641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.
    Chung RT; Gale M; Polyak SJ; Lemon SM; Liang TJ; Hoofnagle JH
    Hepatology; 2008 Jan; 47(1):306-20. PubMed ID: 18161743
    [No Abstract]   [Full Text] [Related]  

  • 32. Pegylated interferon and ribavirin treatment for chronic hepatitis C deteriorates subclinical markers of vascular function.
    Georgiopoulos G; Alexopoulou A; Pouriki S; Vasilieva L; Laina A; Bampatsias D; Mani I; Kontogiannis C; Tousoulis D; Stamatelopoulos K; Dourakis SP
    Hellenic J Cardiol; 2019; 60(2):143-145. PubMed ID: 31146885
    [No Abstract]   [Full Text] [Related]  

  • 33. [Recommendations for the treatment of chronic genotype 1 hepatitis C virus infection].
    Silva MO; Ridruejo E; Galdame O; Bessone F; Colombato L; Daruich J; Fainboim H; Fassio E; Fay F; Frider B; Gadano A; Galoppo MC; González J; Tanno H; Terg R; Villamil F; ;
    Acta Gastroenterol Latinoam; 2012 Sep; 42(3):234-49. PubMed ID: 23214356
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of chronic hepatitis C in hereditary spherocytosis.
    Khokhar N
    Am J Gastroenterol; 2001 Jun; 96(6):1949-50. PubMed ID: 11419867
    [No Abstract]   [Full Text] [Related]  

  • 35. Tailoring the length of antiviral treatment for hepatitis C.
    Mangia A; Andriulli A
    Gut; 2010 Jan; 59(1):1-5. PubMed ID: 20007952
    [No Abstract]   [Full Text] [Related]  

  • 36. SEN viruses and treatment response in chronic hepatitis C virus.
    Enomoto M; Nishiguchi S
    Lancet; 2002 May; 359(9319):1780-1. PubMed ID: 12049898
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of hepatitis C in 2011.
    Williams R; Khan AG
    J Ayub Med Coll Abbottabad; 2010; 22(3):1-2. PubMed ID: 22338403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatitis C virus ten years after its discovery].
    Bralet MP; Dhumeaux D; Zafrani ES
    Ann Pathol; 1999 Dec; 19(6):499-512. PubMed ID: 10617807
    [No Abstract]   [Full Text] [Related]  

  • 39. Next-generation sequencing analysis of new genotypes appearing during antiviral treatment of chronic hepatitis C reveals that these are selected from pre-existing minor strains.
    Iwona BO; Karol P; Kamila CC; Pollak A; Hanna B; Agnieszka P; Andrzej H; Kosińska J; Płoski R; Tomasz L; Marek R
    J Gen Virol; 2018 Dec; 99(12):1633-1642. PubMed ID: 30394872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C.
    el-Sayed AM; Sharara AI
    J Med Liban; 2001; 49(2):71-7. PubMed ID: 11910970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.